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Abstract. 
 
Retinal ganglion cell axons and axonal elec-
trical activity have been considered essential for migra-
tion, proliferation, and survival of oligodendrocyte
lineage cells in the optic nerve. To deﬁne axonal re-
quirements during oligodendrogenesis, the develop-
mental appearance of oligodendrocyte progenitors and 
oligodendrocytes were compared between normal and 
transected optic nerves. In the absence of viable axons, 
oligodendrocyte precursors migrated along the length 
of the nerve and subsequently multiplied and differen-
tiated into myelin basic protein–positive oligodendro-
cytes at similar densities and with similar temporal and 
spatial patterns as in control nerves. Since transected 
optic nerves failed to grow radially, the number of oli-
godendrocyte lineage cells was reduced compared with 
control nerves. However, the mitotic indices of progeni-
tors and the percentage of oligodendrocytes undergo-
ing programmed cell death were similar in control and 
transected optic nerves. Oligodendrocytes lacked their 
normal longitudinal orientation, developed fewer, 
shorter processes, and failed to form myelin in the 
transected nerves. These data indicate that normal den-
sities of oligodendrocytes can develop in the absence of 
viable retinal ganglion axons, and support the possibil-
ity that axons assure their own myelination by regulat-
ing the number of myelin internodes formed by individ-
ual oligodendrocytes.
Key words: oligodendrocyte progenitor cells • axon–
glial interactions • myelination • optic nerve • program 
cell death
 
M
 
YELINATION
 
 of optic nerve axons requires mi-
gration of oligodendrocyte progenitor cells
(OPCs)
 
1
 
 into the optic nerve and proliferation
and differentiation of OPCs into oligodendrocytes fol-
lowed by axonal ensheathment and myelination. The ap-
pearance of OPCs, oligodendrocytes, and myelin in the
optic nerve follows a reproducible temporal and spatial
pattern. Precursor cells enter the rat optic nerve before
birth and colonize the nerve in a chiasmal-to-retinal gradi-
ent during the first postnatal week (Small et al., 1987). Dif-
 
ferentiated oligodendrocytes are first detected 
 
z
 
4 d after
birth (P4) in the chiasmal end of the optic nerve, and pop-
ulate the nerve in a chiasmal-to-retinal gradient between
P4 and P7 (Colello et al., 1995). Myelin is first detected
around P6, and myelination progresses in a retinal-to-chi-
asmal gradient (Skoff et al., 1980; Colello et al., 1995).
What regulates oligodendrocyte production and myelina-
tion in the optic nerve is unknown. It may be that myelina-
tion constitutively follows the colonization of the optic
nerve by precursor cells. Alternatively, environmental fac-
tors, possibly derived from the retinal ganglion cell axons,
may regulate oligodendrocyte production and myelina-
tion.
Since all appropriate axons are faithfully myelinated in
the normal central nervous system, it seems likely that ax-
ons control some aspects of oligodendrocyte development
or myelination. Axons could directly or indirectly control
OPC migration or proliferation, oligodendrocyte differen-
tiation or survival, or the number of myelin internodes
formed by each oligodendrocyte. Viable axons have been
proposed to play a direct and essential role in the genera-
tion and survival of newly formed oligodendrocytes in the
developing rat optic nerve (Barres et al., 1992, 1993;
Barres and Raff, 1993, 1994; Raff et al., 1993). In contrast,
prolonged oligodendrocyte survival (up to 22 mo) has
been reported following transection of P18 or older rat op-
 
tic nerves (Kidd et al., 1990; Ludwin, 1990; McPhilemy
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Abbreviations used in this paper:
 
 BrdU, bromodeoxyuridine; MBP, my-
elin basic protein; OPC, oligodendrocyte progenitor cell; PCD, pro-
grammed cell death. 
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et al., 1990), and oligodendrocytes can be generated in
vitro from precursor cells in the absence of continuous ax-
onal signals (Raff et al., 1983; Zeller et al., 1985; Dubois-
Dalcq et al., 1986; Pfeiffer et al., 1993).
Three distinct stages of oligodendrocyte lineage cells
have been characterized in the developing rodent brain
(Trapp et al., 1997): OPCs that express the integral mem-
brane chondroitin sulfate proteoglycan, NG2, and the 
 
a
 
receptor for the PDGF (PDGF
 
a
 
R) (Levine and Nish-
iyama, 1996; Nishiyama et al., 1996a,b; Trapp et al., 1997);
premyelinating oligodendrocytes that express myelin pro-
teins and extend processes but do not ensheath axons
(Warrington and Pfeiffer, 1992; Hardy and Friedrich, Jr.,
1996; Trapp et al., 1997); and myelinating oligodendro-
cytes. The optic nerve offers several advantages for inves-
tigating oligodendrocyte development. The majority of
precursor expansion and all of oligodendrocyte differenti-
ation and myelination occur postnatally and can be easily
assayed. Furthermore, the nerve is easily transected or
enucleated without compromising the viability of the ani-
mal, and thus provides an ideal setting for investigating the
role of viable axons in oligodendrocyte lineage develop-
ment.
In this study, optic nerve transection and retina ablation
paradigms were used to investigate the consequences of
axonal loss on OPC migration and proliferation and on
oligodendrocyte differentiation and survival. Immunocy-
tochemical characterization and quantitative analysis of
OPCs and oligodendrocytes in enucleated and transected
optic nerves demonstrate that OPCs can colonize the optic
nerve and produce oligodendrocytes in the absence of via-
ble axons. Retinal ganglion cell axons appear essential for
elaboration of the normal three-dimensional organization
of oligodendrocytes and for myelination.
 
Materials and Methods
 
Optic Nerve Transection and Retinal Ablation
 
Newborn (P0) and 4-d-old (P4) Sprague Dawley rat pups were anesthe-
tized with methoxyflurane, the left eye was gently raised with forceps, and
the optic nerve was transected with microscissors between the retinal ex-
cavation and lamina cribrosa. Alternatively, the left cornea of P0 rats was
cut, the vitreous body and the lens removed, and the retina was mechani-
cally ablated. The right optic nerves served as nonoperated controls.
 
Tissue Preparations
 
Rat pups (P0–P7) were anesthetized as described above and perfused
through the heart with 4% paraformaldehyde in 0.08 M Sorensen’s phos-
phate buffer (pH 7.6). The optic nerves were removed and immersed in
the fixative (3 d, 4
 
8
 
C). Longitudinal, free-floating sections (20-
 
m
 
m thick)
were cut on a freezing, sliding microtome. Nerves used for identification
of oligodendrocytes were microwaved in citrate buffer (pH 6.0, three
times for 3 min) before sectioning.
 
Immunoperoxidase Staining
 
Sections were placed in PBS containing 10% Triton X-100 and 1% H
 
2
 
O
 
2
 
(30 min), and incubated in PBS containing 3% normal goat serum (30
min). Sections were exposed to primary antibodies at 4
 
8
 
C (NG2 antibod-
ies overnight, myelin basic protein [MBP] or activated caspase-3 antibod-
ies for 5 d). The sections were then placed in biotinylated goat anti–rabbit
Ig or goat anti–mouse Ig (60 min), and peroxidase-conjugated avidin (60
min). Immunoperoxidase staining was developed by metal enhanced di-
aminobenzidine (Pierce). The sections were treated with 0.04% osmium
tetroxide (20 s), mounted in glycerol, and examined with a Zeiss Axiophot
microscope.
 
Quantification of OPC Density
 
Progenitor cell density was quantified by counting NG2-labeled cell bod-
ies in optic nerves from P0-transected and control optic nerves at P1, P2,
P3, and P4 using a 40
 
3
 
 objective lens, a rectile (10 
 
3
 
 10 grid), and Zeiss
Axiophot microscope. From four to five control and transected optic
nerves at each age, two to three longitudinal sections of the entire optic
nerve were examined from the chiasm to the lamina cribrosa. The number
of OPCs per grid area was determined and the total area analyzed in each
section was calculated. The optic nerve sections were divided into three
equally sized segments (chiasmal, mid, and retinal portions). For each
portion, total areas and OPC numbers were calculated and expressed as
OPCs/mm
 
2
 
 tissue.
Explants of isolated retinal, chiasmal, and intermediate regions of rat
optic nerves were prepared from P0 and P4 rats as described previously
(Ono et al., 1997). Explants were grown in collagen gels for at least 7 d
and labeled with mAb O4 according to published protocols (Ono et al.,
1997). The number of explants from each region of the nerve that con-
tained oligodendrocytes at the end of the study was recorded, and the data
from at least three separate experiments were pooled.
 
Measurement of OPC Length
 
To investigate the effect of nerve transection on progenitor cell process
extension, the length of DAB-stained, bipolar NG2 cells was measured in
P0-transected (
 
n
 
 5 
 
26 cells) and control (
 
n
 
 5 
 
44 cells) optic nerves at P1.
 
Bromodeoxyuridine Incorporation and Double-Labeling 
with NG2
 
Optic nerves were transected at P0 and the rat pups were killed at P2, 90
min after injection with bromodeoxyuridine (BrdU) (i.p.; 0.1 mg/g body
weight) (Boehringer Mannheim). Sections were cut as described above
and pretreated with 10% Triton X-100 in PBS (30 min), 2 N HCl (10 min),
4% sodium borate (10 min), and 3% goat serum in PBS (30 min). The sec-
tions were incubated with NG2 and BrdU antibodies overnight at 4
 
8
 
C,
and were then exposed to biotinylated goat anti–rabbit Ig and Texas red–
conjugated donkey anti–rat Ig (60 min), and FITC-conjugated avidin (60
min), and examined in a confocal microscope (Leica TCS-NT). To deter-
mine the effect of nerve transection on progenitor proliferation, the per-
centage of NG2-positive cells that were double-labeled by BrdU was com-
pared in two to three sections from P0-transected (
 
n
 
 5 
 
4) and control (
 
n
 
 5
 
4) optic nerves at P2.
 
Quantification of Oligodendrocyte Density
 
To investigate the effect of nerve transection on oligodendrocyte density,
MBP-labeled cells were quantified in sections of P4-transected and con-
trol optic nerves at P5, P6, and P7, as well as in P0 retina-ablated and con-
trol optic nerves at P7. Two to three sections from four to five control and
P4 retinal-ablated optic nerves were analyzed at each age. Total areas of
optic nerve sections analyzed were determined as described above, and
oligodendrocyte density was expressed as cells/mm
 
2
 
 of tissue. Retinal re-
gions of P4, P5, and P6 nerves that contained 
 
,
 
10 oligodendrocytes per
40
 
3
 
 field were excluded from the analysis.
 
Measurement of the Radial Length of
Premyelinating Oligodendrocytes
 
To examine the effect of axonal transection on oligodendrocyte process
formation, the longest radial diameter of premyelinating oligodendrocyte
cell bodies and associated processes was measured in sections from P4-
transected (
 
n
 
 5 
 
90 cells) and control (
 
n
 
 5 
 
52 cells) optic nerves at P6. Sec-
tions were pretreated as described above for fluorescence immuno-
staining, incubated with proteolipid protein (5 d at 4
 
8
 
C), biotinylated goat
anti–rat Ig (60 min), and FITC-conjugated avidin (60 min), and then ex-
amined in a confocal microscope. Analysis was restricted to cells that oc-
cupied clearly defined boundaries. 
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Double-Labeling with MBP and Activated
Caspase-3 Antibodies
 
Sections were pretreated as described for immunoperoxidase staining
above and incubated with MBP and activated caspase-3 antibodies (5 d at
4
 
8
 
C). The sections were then treated with biotinylated goat anti–mouse Ig
and FITC-conjugated donkey anti–rabbit Ig (1 h), and then with Texas
red–conjugated avidin (1 h) and the nucleic acid binding dye propidium
iodide. The preparations were examined in a confocal microscope as de-
scribed above.
 
Quantification of Dying Oligodendrocyte Density
 
To quantify the density of dying oligodendrocytes, the number of acti-
vated caspase-3–positive oligodendrocytes was counted in P4-transected
and control optic nerves at P5, P6, and P7. Two to three sections from four
to five control and P4-transected nerves were examined at each age. Only
activated caspase-3–labeled cells with a clear oligodendrocyte-like shape
or process morphology were counted. Optic nerve section area and dying
oligodendrocyte density were determined as described above. Retinal ar-
eas of nerve sections not containing oligodendrocytes were excluded from
the analysis.
 
Antibodies
 
Primary antibodies are well-characterized and were used at the following
concentrations: rabbit polyclonal NG2 antibody, 1:15,000 (Trapp et al.,
1997); mouse monoclonal MBP antibody, 1:8,000 (SMI-99; Sternberger
Monoclonals, Inc.); rat monoclonal PLP antibody, 1:250 (Agmed, Inc.);
rat monoclonal BrdU antibody, 1:5,000 (Harlan Bio); and rabbit poly-
clonal activated caspase-3 (CM1) antibody, 1:20,000 (Idun Pharmaceuti-
cals, Inc.). Secondary antibodies were purchased from Vector Labora-
tories.
 
Statistical Analysis
 
Unpaired 
 
t
 
 test was used for statistical analysis of progenitor prolifera-
tion indices, progenitor cell length, radial diameter of premyelinating oli-
godendrocytes, and oligodendrocyte density in P0 retina-ablated nerves.
Analysis of variance was used for statistical comparison of progenitor
cell density, oligodendrocyte density, and dying oligodendrocyte density
in controls and transected optic nerves. The data were expressed as
means 
 
6 
 
SD.
 
Electron Microscopy
 
To verify that all axons degenerate after P0 retinal ablation and P4
transection, optic nerves were examined by electron microscopy. Retinal
ablation and optic nerve transection were performed as described above,
and the pups were anesthetized and perfused through the heart with 4%
paraformaldehyde, 2.5% glutaraldehyde, and 0.08 M Sorenson’s buffer at
2, 14, 24, 48, and 96 h after treatment. Optic nerves were removed, im-
mersed in the fixative (3 d at 4
 
8
 
C), postfixed with 1% osmium tetroxide
(1 h), dehydrated, and embedded in Epon. Ultrathin sections were cut on
an ultramicrotome (Ultracut E; Reichert), collected on Formvar-coated
slot grids, counterstained with uranyl acetate and lead citrate, and exam-
ined in a Philips CM-100 electron microscope. Midportions of three optic
nerves were examined at each time point.
 
Results
 
Oligodendrocyte Progenitors Appear in a
Chiasmal-to-Retinal Sequence
 
Previous in vitro studies suggest that OPCs enter the chi-
asmal end of the rat optic nerve before birth, and populate
the entire nerve by P9 (Small et al., 1987). However, direct
demonstration of the distribution and morphology of
OPCs in the intact and transected nerve has not been de-
scribed. Therefore, sections of developing and transected
optic nerve were labeled with antibodies specific for NG2,
a sulfated proteoglycan that colocalizes with the PDGF re-
 
ceptor on OPCs in vitro and in vivo (Nishiyama et al.,
1996a,b, 1997). Consistent with in vitro studies (Small et al.,
1987), NG2 antibodies progressively stained more optic
nerve cells in a chiasmal-to-retinal gradient between P0
and P4. Most NG2-positive cells were elongated (Fig. 1 A)
or stellate-shaped (Fig. 1 B). Elongated cells were en-
riched at the migratory front of the NG2 cell population,
always oriented parallel to developing axons, and their
processes often terminated in growth cone–like exten-
sions.
The densities of elongated and stellate-shaped NG2
cells were quantified in chiasmal, mid, and retinal thirds of
P0–P4 optic nerves (Fig. 1 C). Collectively, there was a
greater than sixfold increase in the density of NG2 cells
between P0 and P4. In a chiasmal-to-retinal gradient along
the developing optic nerve, elongated cells were detected
before stellate cells, suggesting that the elongated cells
were more immature and migratory. Elongated cells
reached an optimal density (
 
z
 
200–300 cells/mm
 
2
 
) in all
three regions of the optic nerve at P3. Between P2 and P4,
the density of stellate-shaped cells progressively increased
at all levels of the nerve, suggesting a transition from elon-
gate to stellate morphology during maturation.
To confirm that the distribution of NG2-positive cells
accurately represented the location of oligodendrocyte
precursors in the postnatal nerve, isolated explants of chi-
asmal, mid, and retinal thirds of P0 and P4 nerves were
grown in vitro for 7 d and assayed for O4-positive cells. O4
recognizes sulphatide and other minor lipid components
expressed by oligodendrocytes and some oligodendrocyte
progenitors (Warrington and Pfieffer, 1992). Greater than
96% (34/35) of chiasmal-derived explant contained O4-
positive cells at both ages. In contrast, 44% (13/29) of mid
and 25% of retinal (14/56) explants contained O4-positive
cells in P0 explants, whereas 
 
z
 
80% of mid (10/12) and ret-
inal (11/13) explants contained O4-positive cells in P4
explants. These data provide independent support for
the  migration of NG2-positive oligodendrocyte precursors
along the postnatal optic nerve.
 
Similar Densities of OPCs Develop in Control and 
Transected Optic Nerves
 
To investigate whether the absence of axons influenced
the developmental appearance, morphology, or density of
OPCs, optic nerves were transected near the retina at P0
and analyzed at P1, P2, P3, and P4. The general distribu-
tion of NG2 cells was similar in sections from control and
transected optic nerves. However, the morphology of NG2
cells was affected by nerve transection. Although NG2
cells could still be divided into two general morpholo-
gies, elongated (Fig. 1 D) and stellate (Fig. 1 E), the pro-
cesses of OPCs were generally shorter than those in con-
trol nerve. For example, processes of elongated cells in
transected nerves at P1 were significantly (
 
P
 
 , 
 
0.0001)
shorter (66
 
 6 
 
20 vs. 132
 
 6 
 
52 
 
m
 
m) and more torturous than
those in control nerves. Stellate cells in transected nerves
extended fewer processes, and surface labeling of peri-
karya was more irregular (Fig. 1 E). These data suggest
that the loss of viable axons and/or pathological changes
that follow axonal transection alters the elaboration of
normal OPC morphology. To investigate whether axons 
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influence OPC density, the number of NG2-positive cells
per unit area of tissue was compared in sections from P1,
P2, P3, and P4 control and P0-transected optic nerves. At
all ages, the density of NG2 cells/mm
 
2
 
 of tissue was similar
in control and transected optic nerve (Fig. 1 F).
The progressive increase in NG2-positive cells after P0
optic nerve transection suggested that viable axons were
not required for OPC proliferation. A BrdU incorporation
assay was used to compare levels of NG2 cell proliferation
in transected and normal nerves. In P2 control (Fig. 2, A
and B) and P2 optic nerves transected at P0 (Fig. 2 C), nu-
clei of both elongated and stellate NG2 were BrdU-posi-
tive after a 2-h pulse. Approximately 25% of all NG2-
positive cells were BrdU-positive in both control and
transected optic nerves (Fig. 2 D), indicating that viable
axons and neuronal electrical activity are not essential for
OPC proliferation in vivo.
 
Density and Timing of Oligodendrocyte Development Is 
Not Affected by Optic Nerve Transection
 
To investigate the influence of axons on the development
of differentiated oligodendrocytes, the distribution and
morphology of MBP-positive cells were compared at P5,
P6, and P7 in normal and optic nerves transected at P4
(Fig. 3 A). In the normal optic nerve at the time of transec-
tion (P4), there was no detectable myelin, and MBP-posi-
tive oligodendrocytes were detected only in the chiasmal
third of the nerve. These oligodendrocytes appeared in
clusters of two to three cells, which extended multiple pro-
cesses radially. 1 d later at P5, there was no detectable my-
elin, and MBP-positive oligodendrocytes were restricted
to the chiasmal half of control nerves (Fig. 3 A). These
cells had a similar appearance to those at P4. In transected
optic nerves at P5, there was no detectable myelin, and
as in control nerves, the MBP-positive oligodendrocytes
were restricted to the chiasmal half of the nerve (Fig. 3 A).
Compared with P5 control nerves, individual oligodendro-
cytes extended fewer and shorter processes (data not
shown).
In control nerves at P6, MBP immunoreactive oligoden-
drocytes (Fig. 3 A) were present throughout the chiasmal
two thirds of the nerve. Although most MBP-positive cells
had the appearance of premyelinating oligodendrocytes
and occurred in clusters of two or three cells (Fig. 3 B),
some extended processes that ran parallel to axons. In P4-
transected nerves analyzed at P6, MBP-positive cells were
also detected throughout the chiasmal two thirds of the
nerve (Fig. 3 A). The morphology of these MBP-positive
cells differed from those in control nerves in that their pro-
cesses were shorter and more asymmetrically distributed
(Fig. 3 C).
In control nerves at P7, MBP-positive oligodendrocytes
were detected along the entire length of the nerves. My-
elin was detected along the entire optic nerve, with highest
concentrations at the retinal end. The MBP-positive cell
Figure 1. NG2 cells colonize the optic
nerve in the absence of viable axons. In
control nerves, NG2 cells displayed
two morphologies: elongated (A) and
stellate-shaped (B). Between P0 and
P4, NG2 cells increased in a chiasmal-
to-retinal gradient. Elongated and stel-
late cells were quantified per mm2 of
tissue in the chiasmal, mid, and retinal
third of longitudinal sections from
nerves at P0, P1, P2, P3, and P4 (C).
Between P0 and P3, elongated cells (C,
black boxes) were enriched at the lead-
ing edge of the migrating front, and
their processes were always oriented
parallel to developing axons (A). The
density of NG2 cells increased sixfold
between P0 and P4 (C), and stellate-
shaped cells comprised 88% of the to-
tal NG2 cells at P4. The morphology
and density of NG2 cells were deter-
mined following optic nerve transec-
tion at P0. Both elongated (D) and stel-
late-shaped (E) NG2 cells were
detected in P1-, P2-, P3-, and P4-
transected optic nerves, and NG2 cell
distribution and density (F) were simi-
lar to those detected in P1–P4 control
nerves. However, the processes extend-
ing from these NG2 cells were shorter
and irregularly shaped. Bar, 20 mm. 
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bodies were less clustered at P7 than the premyelinating
oligodendrocytes at P6, and were generally located in lon-
gitudinally oriented chains parallel to the axons (Fig. 3 D).
In P4 transected nerves analyzed at P7, myelin was not de-
tected, although MBP-positive oligodendrocytes were dis-
tributed along the entire length of the optic nerve (Fig.
3 A). These oligodendrocytes were frequently clustered
without any particular orientation (Fig. 3 E).
To investigate whether axons influence oligodendrocyte
density in the optic nerve, the number of MBP-positive
cells per unit area of tissue was compared in sections of P5,
P6, and P7 control and P4-transected optic nerves (Fig. 3
F). In sections of P4 control nerves, MBP-positive cells
were detected at a density of 380 cells/mm
 
2
 
 of tissue (Fig. 3
F). 1 d later at P5, the density increased to 700 cells/mm
 
2
 
 of
tissue. At P5, the density of oligodendrocytes was signifi-
cantly reduced in P4-transected nerves (361 cells/mm
 
2
 
 tis-
sue). Although the overall distribution of oligodendro-
cytes increased in P6 control nerves, their density (622
cells/mm
 
2
 
 tissue) was similar to that observed at P5. At P6,
the density of MBP-positive oligodendrocytes was similar
in control (621 cells/mm
 
2
 
 tissue) and P4-transected (642
cells/mm
 
2
 
 tissue) nerves. Between P6 and P7, the density
of oligodendrocytes increased and was similar in both con-
trol (1,157 cells/mm
 
2
 
 tissue) and transected (1,205 cells/
mm
 
2
 
 tissue) optic nerves.
A consistent observation in transected optic nerves was
an apparent reduction in the number and length of pro-
cesses extending from premyelinating oligodendrocytes.
Quantification of premyelinating oligodendrocyte process
length in confocal microscopic images of control (Fig. 4 A)
and P4-transected (Fig. 4 B) nerves at P6 detected a 50%
reduction in the radial extensions of oligodendrocyte pro-
cesses in the transected nerves (Fig. 4 C). The number of
processes was clearly reduced in transected nerves, al-
 
though quantification was difficult due to the complexity
of processes in normal nerves.
 
Optic Nerve Transection and Oligodendrocyte
Cell Death
 
Cell death of premyelinating oligodendrocytes is a charac-
teristic feature of oligodendrocyte lineage development
(Barres et al., 1992; Raff et al., 1993; Trapp et al., 1997).
Programmed cell death (PCD) requires the activation of a
family of activator and effector cysteine protease enzymes
referred to as caspases (Ellis et al., 1991; Alnemri et al.,
1996; Thornberry and Lazebnik, 1998). Caspases are ex-
pressed as inactive proenzymes. Upon activation, caspases
are cleaved into smaller catalytically active subunits. Acti-
vated caspase-3 is a downstream effector of PCD in a vari-
ety of cell types (Kuida et al., 1996; Cecconi et al., 1998;
Namura et al., 1998; Srinivasan et al., 1998), including oli-
godendrocytes maintained in vitro (Gu et al., 1999). It is
expressed as a 32-kD inactive proenzyme. The antibody
used in this study selectively recognizes the enzymatically
active p18 subunit of caspase-3 (Gu et al., 1999). To inves-
tigate whether P4 optic nerve transection influenced the
extent of oligodendrocyte PCD, the number of dying oli-
godendrocytes was compared in sections from P5, P6, and
P7 control and P4-transected nerves. Dying premyelinat-
ing oligodendrocytes were identified by fragmentation
of myelin protein–positive processes, condensed nuclear
chromatin, and the presence of activated caspase-3 (Fig. 5,
A–C). Double-labeling immunocytochemistry colocalized
activated caspase-3 and MBP in sections of control and
transected nerves (Fig. 5, A and B). Double-labeled cells
had the morphology of premyelinating oligodendrocytes.
As described previously (Trapp et al., 1997), most (97%)
had fragmented MBP-stained processes (Fig. 5) and con-
densed nuclear chromatin as detected by propidium io-
dide staining (data not shown). The remaining 3% of acti-
vated caspase-3–positive oligodendrocytes were probably
in early stages of PCD before process fragmentation and nu-
clear chromatin condensation. Occasional caspase-3–posi-
tive myelinating oligodendrocytes were detected in con-
trol nerves. Activated caspase-3–positive NG2 cells were
not detected in either control or transected nerves (data
not shown). Activated caspase-3–positive, MBP-negative
cells were also detected. These cells did not extend acti-
vated caspase-3–positive processes and they were often lo-
cated next to vessels. At P5, there was a small but signifi-
cant increase in the proportion of dying oligodendrocytes
in transected optic nerves (Fig. 5 D). At P6 and P7, the
percentage of activated caspase-3–positive oligodendro-
cytes was similar in control and transected optic nerves
(Fig. 5 D), indicating that the absence of viable axons and
axonal electrical activity did not significantly increase the
extent of oligodendrocyte cell death, 2 and 3 d after P4
nerve transection.
 
Oligodendrocyte Lineage Develops throughout the Optic 
Nerve in the Absence of Axons
 
The studies described above independently investigated
the role of axons in (a) OPC appearance following P0 op-
tic nerve transection; and (b) oligodendrocyte appearance
after P4 optic nerve transection. To investigate if OPCs
Figure 2. NG2 cell proliferation indices are similar in control and
transected optic nerves. After a 90-min BrdU pulse at P2, the
percentages of BrdU and NG2-positive cells were compared in
control and P0-transected nerves. Sections were analyzed by con-
focal microscopy to assure precise identification of BrdU-labeled
(A–C, red) NG2-positive cells (A–C, green). Both elongated and
stellate-shaped NG2 cells incorporated BrdU in control (A and
B) and transected (C) nerves. Quantification of NG2 and BrdU-
positive cells as a percentage of total NG2 cells detected similar
(P 5 0.31) BrdU-labeling indices in control and transected
nerves (D). Bar, 20 mm. 
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can colonize the optic nerve and produce oligodendro-
cytes in the absence of viable axons, retinas of newborn
(P0) rats were mechanically ablated and the optic nerves
analyzed for oligodendrocytes using immunocytochemis-
try and MBP antibodies 1 wk later at P7. Compared with
control nerves (Fig. 6 A), retina ablation at P0 drastically
reduced the width of the optic nerve at P7 (Fig. 6 B), but
these nerves retained their normal length, and thus pro-
vided a substantial substrate for OPC migration. In elec-
tron micrographs from midregions of nerves 14 h after P0
retinal ablation, all axons were in advanced stages of de-
generation (data not shown). Axonal fragments were de-
tected 24 h after ablation, were rare at 48 h, and unde-
tected at 4 d. The marked decrease in optic nerve volume
(Fig. 6 B) also supports total loss of axons in this experi-
mental paradigm. In both control (Fig. 6 A) and P0 reti-
nal-ablated (Fig. 6 B) optic nerves, oligodendrocytes were
present along the entire length of the nerve at P7. How-
ever, quantification of MBP-positive cells at P7 demon-
strated a 50% reduction in the density of oligodendrocytes
(Fig. 6 C) and a total absence of myelination following P0
retinal ablation. These studies establish that OPCs can col-
onize regions of the optic nerve and produce oligodendro-
cytes in the absence of viable axons.
 
Discussion
 
A prevailing notion suggests that retinal ganglion cell ax-
ons play a critical role in several aspects of the develop-
ment of optic nerve oligodendrocytes (Barres et al., 1992,
1993; Barres and Raff, 1993, 1994; Raff et al., 1993). In this
study, we demonstrate that axonal transection inhibited
myelin formation, altered the three-dimensional organiza-
tion of oligodendrocytes, and reduced the number and
length of oligodendrocyte processes. However, the tempo-
ral and spatial appearance and density of optic nerve
OPCs and oligodendrocytes were similar in control and
transected optic nerves. These data demonstrated that oli-
godendrogenesis occurs in the absence of viable retinal
ganglion cell axons and argues against direct axonal regu-
Figure 3. Oligodendrocytes populate
the optic nerve in the absence of viable
axons. Immunocytochemical detection
of MBP-positive oligodendrocytes in
sections from control (A, left column)
and P4-transected (A, right column)
optic nerves at P5, P6, and P7. At the
time of transection (P4), oligodendro-
cytes were restricted to the chiasmal
third of the nerve. In P5 control nerves,
MBP-positive oligodendrocytes were
detected within the chiasmal half of the
nerve. P4 transection reduced the num-
ber but not the general distribution of
MBP-positive cells in P5 nerves. At P6
and P7, the general distribution of
MBP-positive oligodendrocytes was
similar in control and P4-transected op-
tic nerves. Oligodendrocytes in P6 con-
trol nerves (B) and transected nerves
(C) occur in clusters of two to three
cells. Processes extending from oligo-
dendrocytes appear shorter and less
complex in transected nerves at P6. At
P7, myelin is abundant in control nerves
(D) but not detected in P4-transected
(E) nerves. Oligodendrocytes remain in
clusters in P7 nerves transected at P4
(E). P4 nerve transection induced a re-
duction in the density of oligodendro-
cytes detected at P5, but not at P6 or P7
(F). Bars: 1 mm (A); 50 mm (B–E). Ar-
rows indicate oligodendrocyte cell bod-
ies. Asterisk in F indicates P , 0.0001
based on Fisher’s test. 
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lations of optic nerve oligodendrogenesis. Because axon-
depleted nerves fail to grow radially, they do contain fewer
OPCs and oligodendrocytes, indicating that axons indi-
rectly influence oligodendrocyte lineage cell number by
increasing optic nerve volume.
 
Oligodendrocyte Lineage following Optic
Nerve Transection
 
This and previous studies that supported direct axonal reg-
ulation of oligodendrocyte lineage development (Barres
et al., 1992, 1993; Barres and Raff, 1993) both used optic
nerve transection paradigms. However, they diverged in
the methods used to identify and quantify OPCs and oligo-
dendrocytes and in the postnatal age of optic nerve
transection. Previous studies often used indirect immuno-
cytochemical techniques (i.e., delivery of antibody in vivo
by intraventricular transplantation of hybridoma cells) to
identify and quantify OPCs and oligodendrocytes, and
concluded that loss of viable axons caused decreased OPC
proliferation (Barres and Raff, 1993) and increased death
of oligodendrocytes (Barres et al., 1993). This study used
recently developed (Trapp et al., 1997) immunocytochem-
ical methods to identify and quantify OPCs and oligoden-
drocytes in fixed sections of control and transected optic
nerves. These methods label OPCs and premyelinating oli-
godendrocytes in a predictable temporal and spatial pat-
tern during brain (Trapp et al., 1997) and optic nerve de-
velopment, and they establish in this report that the
percentage of BrdU-labeled OPCs and dying oligodendro-
cytes are similar in control and transected optic nerves.
The OPC proliferation data may be consistent between
the studies, and the differences reported may reflect the
denominators used to express the data (total BrdU-posi-
tive OPCs in Barres et al., 1993, and Barres and Raff,
1993; percentage of total OPCs in this study). In electron
micrographs, all axons were fragmented and in advanced
stages of degeneration by 14 h after transection and reti-
nal ablation. Therefore, our studies established that oligo-
dendrocyte production in vivo can occur in the absence
of viable axons and neuronal electrical activity. Small
amounts of axonal debris remained at 24 h after transec-
tion, and could have some effect on oligodendrocyte lin-
eage. A similar time course of axonal degeneration was re-
Figure 4. Axonal transection reduces the length and number of
premyelinating oligodendrocyte processes. The morphology of
premyelinating oligodendrocytes was investigated by confocal
microscopy at P6. Premyelinating oligodendrocytes in control
sections extended multiple processes that branched extensively
(A). Premyelinating oligodendrocytes in transected nerves often
occurred in clusters (B) and extend few, short processes. The ra-
dial extent of processes was significantly (*P , 0.0001) reduced
in transected nerves (C). A and B are 1.0-mm-thick optic sections.
Asterisks in A and B indicate oligodendrocyte nuclei. Bar, 20 mm.
Figure 5. Oligodendrocyte PCD is similar in control and
transected optic nerves. Sections of control and transected optic
nerves were double-labeled with MBP (red) and caspase-3
(green) antibodies and examined by confocal microscopy (A and
B). Caspase-3 immunoreactivity was enriched in the cell body of
MBP-positive cells. Most (A) but not all (B) MBP caspase-3–pos-
itive cells had fragmented MBP-stained processes. Compared
with control nerves, caspase-3–positive cells/mm2 of tissue (C)
were increased in transected nerves at P5 (*P , 0.01), but un-
changed at P6 and P7 (D). Bars: 10 mm (A and B); 20 mm (C). 
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ported in optic nerves transected during the second and
third postnatal week (Barres et al., 1992, 1993). Therefore,
it is unlikely that axonal debris accounts for significant dif-
ferences between this and previous studies.
A major objective of this study was to investigate the
role of viable axons on OPC colonization of optic nerve
and their subsequent differentiation into oligodendro-
cytes. Past studies supporting axonal regulation of oligo-
dendrocyte lineage analyzed optic nerves transected dur-
ing the second and third postnatal week. It is possible that
oligodendrocyte lineage is differentially regulated during
different stages of optic nerve development. However,
previous immunocytochemical studies (Kidd et al., 1990)
detected normal numbers of oligodendrocytes 5, 10, 20,
and 40 d after P21 optic nerve transection. In addition, my-
elin protein mRNA in these P21-transected optic nerves
decreased gradually and depending on the mRNA, repre-
senting between 25 and 60% of mRNA levels in control
nerves at 40 d after transection. Similarly, two additional
studies (McPhilemy et al., 1990; Ludwin, 1990) failed to
detect a decrease in oligodendrocytes after P18 or older
optic nerve transection. These data indicate that oligoden-
drocytes do not die after P18 optic nerve transection and/or
that new oligodendrocytes are generated. Both events are
inconsistent with the hypothesis that viable axons directly
regulate oligodendrocyte lineage.
 
The Migration and Proliferation of Optic Nerve OPCs 
Do Not Depend on Viable Axons
 
The distribution and morphology of OPCs in the intact de-
veloping optic nerve and the pattern of oligodendrogene-
sis in explants isolated from P0 and P4 optic nerve were
consistent with previous analyses, suggesting that OPCs
enter the chiasmal end of the rat optic nerve just before
birth and reach confluency along the nerve by P9 (Small
et al., 1987). Elongated NG2-positive cells were enriched
at the migratory front of the OPCs and had a morphology
very similar to the migratory OPCs in the chick optic
nerve (Ono et al., 1997). These cells were invariably ori-
ented parallel with the optic axons and their process often
terminated in growth cone–like structures. It seems likely
that with maturation, some elongate cells develop into
stellate cells, since the density of the stellate cells in-
creased significantly in older nerves. The cellular sub-
strates used by migrating OPCs are unknown. While axons
are a candidate for such a substrate (Ono et al., 1997), our
P0 retinal ablation study establishes that OPCs can mi-
grate the length of the optic nerve in the absence of viable
retinal axons, and migrate after P2 in the absence of de-
tectable axonal fragments. Other potential substrates in
the transected nerves include astrocytes and longitudinally
oriented blood vessels. Indeed, NG2 cell bodies and the
processes of NG2-positive cells frequently terminated
near or associated with blood vessels. OPC migration on
the extracellular matrix of astrocytes or endothelial cells
would support the in vitro finding that specific integrin ex-
pression may regulate OPC migration (Milner et al., 1996).
Previous studies suggested that OPC proliferation in the
developing optic nerve was driven through release of the
mitogen PDGF that was dependent on axonal electrical
activity (Barres and Raff, 1993). By contrast, this study
clearly establishes that viable axons and electrical activity
are not essential for the mitosis of OPCs and for expansion
of oligodendrocyte lineage cells in the optic nerve. Our
data are consistent with the normal myelination in P9 op-
tic nerves following intraocular injection of tetrodotoxin
every 2 d starting at P0 (Colello et al., 1995). As suggested
previously, our data support mitogenic stimulation of OPC
proliferation by factors released from astrocytes and/or
endothelial cells. Astrocytes are a major source of PDGF
(Raff et al., 1988), and conditioned medium from purified
cultured type I astrocytes is a strong mitogen for purified
OPCs (Noble and Murray, 1984).
 
The Differentiation of Oligodendrocytes Is Not 
Dependent on Optic Axons
 
In the normal rat optic nerve, in situ hybridization studies
of myelin protein mRNA (Colello et al., 1995) and the dis-
tribution of MBP (Fig. 3) describe a chiasmal-to-retinal
gradient in the developmental appearance of oligodendro-
cytes. However, myelination proceeds in a retinal-to-chi-
asmal gradient (Skoff et al., 1980; Colello et al., 1995), sug-
gesting that oligodendrocyte maturation and the induction
of myelination are independently regulated. Oligodendro-
cytes mature to the MBP-positive stage but fail to initiate
myelination in the axon-free environment. Thus, the early
stages of oligodendrocyte development can occur inde-
pendently of direct axonal signals, but myelination is criti-
cally dependent on axons. Axonal control of myelination
is further supported by the differences we observed in the
Figure 6. OPCs colonize the entire op-
tic nerve and produce oligodendrocytes
in the absence of viable axons. Retinas
of rats were surgically ablated at P0,
and the distribution and density of
MBP-positive oligodendrocytes were
determined at P7. Compared with nor-
mal P7 nerves (A), the loss of viable ax-
ons and neuronal electrical activity at
P0 had no effect on the distribution of
oligodendrocytes in P7 nerves (B).
However, the density of oligodendro-
cytes per mm2 of tissue (C) was sig-
nificantly reduced (*P , 0.001). Bar,
500 mm. 
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apparent life span of premyelinating oligodendrocytes at
the retinal and chiasmal ends of the normal optic nerve.
Oligodendrocytes in the chiasmal end of the optic nerve
do not myelinate for at least 2–3 d after their initial detec-
tion by MBP antibodies, whereas oligodendrocytes at the
retinal end of the nerve can myelinate within 24 h or less.
It has been proposed that survival of premyelinating oli-
godendrocytes is determined by a competition for ax-
onally derived trophic signals, and cells that do not receive
such signals within 2–3 d initiate a suicide program (Barres
et al., 1992, 1993; Barres and Raff, 1993, 1994; Trapp et al.,
1997). The distribution of dying premyelinating oligoden-
drocytes along the length of the developing normal optic
nerve suggests that there is not a defined interval between
generation of premyelinating cells and the induction of
PCD. Rather, it may be that oligodendrocyte PCD in nor-
mal optic nerves is induced by positive death signals or
failed development. P4 axonal transection caused a reduc-
tion of oligodendrocyte density and a slight increase in the
percentage of oligodendrocytes undergoing PCD at P5.
However, 2 and 3 d after P4 optic nerve transection, the
density of oligodendrocytes and percentage of oligoden-
drocytes undergoing PCD in control and transected nerves
were similar. These data argue against the hypothesis that
oligodendrocyte survival is primarily dictated by limiting
quantities of axonally derived survival factors.
 
Regulation of Oligodendrocyte Numbers and 
Myelination in Optic Nerve
 
The number of optic nerve myelin internodes formed is
precisely matched to the number of axons requiring my-
elination. How such matching is achieved is unclear. One
hypothesis is that the number of axons directly regulates
the number of oligodendrocytes (Barres and Raff, 1994).
Consistent with this notion, when the number of axons is
increased in the optic nerve, oligodendrocyte numbers in-
creased proportionally (Burne et al., 1996). Our data sug-
gest that this simple correlation is incomplete and support
an alternative mechanism. In axon-free transected nerves,
OPC and oligodendrocyte densities are similar to control
nerves, but their total numbers are decreased because the
nerve fails to grow radially due to loss of axons and failed
myelination. Since oligodendrocyte lineage cell density is
regulated by a homotypic density-dependent inhibition of
OPC proliferation in vitro (Zhang and Miller, 1996), one
possible mechanism operating in developing optic nerves
is that the OPCs proliferate until they reach a critical den-
sity. Increasing or decreasing the size of the nerve through
addition or loss of axons will change the potential area,
and thus the number of OPCs and oligodendrocytes, but
does not necessarily articulate direct axonal regulation of
oligodendrocyte number.
Retinal axons are required for the generation of the op-
tic nerve during early development and they may directly
regulate type I astrocyte colonization of the optic nerve, as
astrocytes fail to develop in the optic stalk of mice that do
not form retinas (Robb et al., 1978). This study indicates
that endothelial cells or the astrocytes which bundle
groups of developing axons provide sufficient substrates
for colonization of optic nerves by OPCs, for proliferation
of OPCs, and for production of oligodendrocytes. Endo-
thelial cells have received little attention as a regulator of
oligodendrocyte lineage. Closure of the blood–brain bar-
rier mimics the in vitro conditions (no serum) that drives
oligodendrocyte production from O2A cells (Raff et al.,
1983). Astrocyte–endothelial interactions may regulate
oligodendrocyte lineage by modulating astrocyte expres-
sion of mitotic, chemotactic, and survival factors and by
restricting inhibitory serum factors following blood–brain
barrier closure. If axons indirectly regulate oligodendro-
cyte numbers via type I astrocytes, our data demonstrate
that this axonal influence occurs before P1, and viable ax-
ons need not be present at the time of OPC migration or
oligodendrocyte production.
The faithful match between myelin production and ax-
onal length argues for axonal control of myelination. This
study seriously questions direct axonal regulation of oligo-
dendrocyte number during early stages of optic nerve de-
velopment, and raises the alternative possibility that axons
regulate the number of myelin internodes formed by indi-
vidual oligodendrocytes. In support of this hypothesis,
premyelinating oligodendrocytes in the corpus callosum
and optic nerve extend many processes and form 30–40
thin, short myelin internodes (Trapp et al., 1997). Premy-
elinating oligodendrocytes in the region of cerebral cortex
and spinal cord extend fewer, longer processes and form
few, thick long myelin internodes. Therefore, developing
axons may directly regulate premyelinating oligodendro-
cyte process number, and in turn, myelin internode num-
ber, thereby assuring an appropriate match between oligo-
dendrocyte number and myelination. This matching may
reflect differences in the electrical activity of developing
fiber tracks, or molecules specific to or present at varying
concentrations on different populations of developing
axons.
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